1Kobayashi R,Kaneda M,Sato T,et al.The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases:a 10-year analysis at a single institution at Japan[J].Pediatr Hematol Oncol,2008,30(12):886-900.
3Forrest G.N,Walsh TJ.Approaches to management of invasive fungal infections in patients with hematologic malignancies[J].Support Cancer Ther,2004,2(1):21-30.
4Miyakoshi1 S,Kusumi E,Matsumura T,et al.Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases[J].Biol Blood Marrow Transplant,2007,13(7):771-777.
5Maertens J,Theunissen K,Lodewyck T,et al.Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders[J].Mycoses,2007,50(Suppl 1):2-17.
6Vekemans M,Robinson J,Georgala A,et al.Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy[J].Clin Infect Dis,2007,44(12):1593-1601.
7Girmenia C,Pizzarelli G,Pozzi E,et al.Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia:the role of voriconazole[J].Haematologica,2008,93(1):159-160.
8Ruping MJ,Vehreschild JJ,Cornely OA.Antifungal treatment strategies in high risk patients[J].Mycoses,2008,51(Suppl 2):46-51.
8Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J,2007,30:782- 800.
9Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med,2006 ,173 :707-717.
10Bahme A, Ruhnke M, Buehheidt D iet al. Treatment of invasivefungal infections in cancer patients- recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology ( DGHO). Ann Hematol,2009 ,88 :97-110.
